Formation Bio has appointed Michael Ehlers as chief scientific officer and head of research and development. Ehlers previously served as CEO and president of Ascidian Therapeutics, a company he founded.
But all work and no play can make for a dull chief scientific officer and R&D chief.
Also Read
- Ambient Scribes Improve Clinician Retention, Cleveland Clinic Research Shows
- Expert Roundup: Key Insights on Vaccines, Cannabis, and Public Health This Week
- Clear Eyes Manufacturer Recalls 39,060 Units Due to Potential Contamination[/TITLE>
- Abcuro Secures $66M Series D to Advance Ulviprubart in Less Severe IBM Patients After Disappointing Phase 2/3 Results
